Published in Oncogene on September 05, 1996
A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol (1996) 7.64
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J (1997) 4.80
Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy. Mol Biol Cell (1999) 4.68
The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol (1998) 4.43
Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex. Genes Dev (1998) 3.84
SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol (1998) 3.65
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 3.34
The mechanisms of PML-nuclear body formation. Mol Cell (2006) 3.22
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol (1999) 2.93
TRIM proteins and cancer. Nat Rev Cancer (2011) 2.84
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80
Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J (1999) 2.79
Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol (2000) 2.59
Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol (2002) 2.57
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.54
PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44
RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc Natl Acad Sci U S A (1997) 2.42
ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol (2005) 2.36
Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J Cell Biol (1998) 2.29
An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol (2009) 2.27
Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol (2000) 2.25
Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol (1998) 2.21
A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics (2004) 2.21
An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol (1998) 2.20
Chromatin components as part of a putative transcriptional repressing complex. Proc Natl Acad Sci U S A (1998) 2.14
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol (1998) 2.12
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol (2001) 2.07
The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A (1998) 2.05
Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol (1999) 1.97
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol (2000) 1.91
Role of desumoylation in the development of prostate cancer. Neoplasia (2006) 1.90
ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J Virol (2000) 1.90
Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol (2002) 1.81
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol (2010) 1.73
The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol (2001) 1.70
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69
Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol (2007) 1.65
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 1.65
Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol (1998) 1.64
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet (1998) 1.64
Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J Virol (2003) 1.50
Replication checkpoint kinase Cds1 regulates recombinational repair protein Rad60. Mol Cell Biol (2003) 1.50
SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A (2000) 1.47
The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol Cell Biol (1998) 1.46
A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci U S A (1999) 1.44
The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett (1997) 1.41
Retracted Detection of ubiquityl-calmodulin conjugates with a novel high-molecular weight ubiquitylprotein-isopeptidase in rabbit tissues. Eur J Med Res (2010) 1.39
Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci U S A (1997) 1.36
Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies. Mol Cell Biol (2000) 1.36
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol (2006) 1.32
Human pathogens and the host cell SUMOylation system. J Virol (2011) 1.31
Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J Virol (2001) 1.28
Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol (2013) 1.26
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol (1999) 1.25
Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol (2006) 1.24
Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J (2000) 1.19
Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search. J Biol Chem (2012) 1.19
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol (2012) 1.17
Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol (2009) 1.17
SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem (2010) 1.16
Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol (2012) 1.16
Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A (2001) 1.11
The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc Natl Acad Sci U S A (2000) 1.08
Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein. Nucleic Acids Res (2000) 1.06
Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J Virol (2000) 1.04
Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev (2014) 1.02
Cellular localization, expression, and structure of the nuclear dot protein 52. J Cell Biol (1997) 1.02
Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha. Philos Trans R Soc Lond B Biol Sci (1999) 1.02
The 2 microm plasmid causes cell death in Saccharomyces cerevisiae with a mutation in Ulp1 protease. Mol Cell Biol (2005) 1.00
Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem J (1998) 1.00
SUMO and SUMOylation in plants. Mol Cells (2011) 0.99
Nuclear IE2 structures are related to viral DNA replication sites during baculovirus infection. J Virol (2002) 0.99
Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. J Cell Biol (2002) 0.97
Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1. J Virol (2001) 0.96
Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling. Biochem J (2005) 0.95
Segmentation of fluorescence microscopy images for quantitative analysis of cell nuclear architecture. Biophys J (2009) 0.94
Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon? Biochim Biophys Acta (2008) 0.93
Modification of small hepatitis delta virus antigen by SUMO protein. J Virol (2009) 0.92
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem (2009) 0.91
Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus. Virology (2007) 0.91
The SUMO protease SENP6 is a direct regulator of PML nuclear bodies. Mol Biol Cell (2010) 0.91
PML, SUMOylation, and Senescence. Front Oncol (2013) 0.89
Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol (2014) 0.89
Post-translational modifications of PML: consequences and implications. Front Oncol (2013) 0.88
Influence of ND10 components on epigenetic determinants of early KSHV latency establishment. PLoS Pathog (2014) 0.86
Sumoylation at the host-pathogen interface. Biomolecules (2012) 0.86
KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies. J Cell Sci (2009) 0.85
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods (2011) 0.83
A mechanistic view of the role of E3 in sumoylation. PLoS Comput Biol (2010) 0.83
Identifications of SUMO-1 cDNA and its expression patterns in Pacific white shrimp Litopeanaeus vannamei. Int J Biol Sci (2009) 0.83
Identification of SUMO-interacting proteins by yeast two-hybrid analysis. Methods Mol Biol (2009) 0.82
Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation. J Biol Chem (2013) 0.81
Regulation of the tumor suppressor PML by sequential post-translational modifications. Front Oncol (2012) 0.79
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2008. Nucleic Acids Res (2007) 20.67
Ensembl 2007. Nucleic Acids Res (2006) 20.10
Ensembl 2005. Nucleic Acids Res (2005) 15.13
Ensembl 2006. Nucleic Acids Res (2006) 11.66
The vertebrate genome annotation (Vega) database. Nucleic Acids Res (2007) 7.53
Does this have a familiar RING? Trends Biochem Sci (1996) 4.80
Progress towards construction of a total restriction fragment map of a human chromosome. Nucleic Acids Res (1987) 4.68
Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I. Science (1988) 4.50
Chromosome 5 allele loss in human colorectal carcinomas. Nature (1987) 4.46
A novel cysteine-rich sequence motif. Cell (1991) 4.39
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science (1991) 3.57
Structure of the AAA ATPase p97. Mol Cell (2000) 3.37
Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science (1990) 3.34
The management of cervical carcinoma within the south west region of England. Expert Tumour Panel. Br J Obstet Gynaecol (1997) 3.18
Evolution of sickle variant gene. Lancet (1979) 3.09
PML protein isoforms and the RBCC/TRIM motif. Oncogene (2001) 2.99
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
The RING finger domain: a recent example of a sequence-structure family. Curr Opin Struct Biol (1996) 2.97
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J (1995) 2.93
Identification and characterization of the human type II collagen gene (COL2A1). Proc Natl Acad Sci U S A (1985) 2.80
Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J (1998) 2.68
Report of the committee on the genetic constitution of chromosome 17. Cytogenet Cell Genet (1989) 2.59
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
The crystal structure of the human DNA repair endonuclease HAP1 suggests the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J (1997) 2.53
A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci (1992) 2.51
Mutations affecting the dissimilation of mannitol by Escherichia coli K-12. J Bacteriol (1972) 2.46
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci (1999) 2.46
The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Tissue Antigens (1978) 2.40
A highly polymorphic region 3' to the human type II collagen gene. Nucleic Acids Res (1985) 2.37
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37
The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J Cell Biol (1998) 2.29
The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature (1975) 2.29
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene (1999) 2.09
Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonging recovery. Anesth Analg (1997) 2.09
The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol (1977) 2.08
Joint action of two RNA degradation pathways controls the timing of maternal transcript elimination at the midblastula transition in Drosophila melanogaster. EMBO J (1999) 2.02
Chromosomal localisation of the human homologues to the oncogenes erbA and B. EMBO J (1984) 2.02
Oligomeric ring structure of the Bloom's syndrome helicase. Curr Biol (1999) 2.01
Assignment of the structural gene for the third component of human complement to chromosome 19. Proc Natl Acad Sci U S A (1982) 2.00
Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology (1997) 1.96
Chromosomal localization of human cellular homologues of two viral oncogenes. Nature (1982) 1.96
Isolation and characterization of a human collagen alpha 1(I)-like gene from a cosmid library. Nucleic Acids Res (1982) 1.94
Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science (1988) 1.87
The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol (1982) 1.86
Immunoglobulin heavy chain genes in humans are located on chromosome. Ann Hum Genet (1981) 1.85
Distribution of R plasmids among the O-antigen types of Escherichia coli isolated from human and animal sources. Antimicrob Agents Chemother (1975) 1.83
RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. Mol Cell Biol (1997) 1.83
Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr (1992) 1.79
Crystal structure of the DNA modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. EMBO J (1994) 1.76
Persistence and replication of plasmid DNA microinjected into early embryos of Xenopus laevis. Dev Biol (1988) 1.75
Human elastin gene: new evidence for localization to the long arm of chromosome 7. Am J Hum Genet (1991) 1.69
Complex regulation of the BRCA1 gene. J Biol Chem (1997) 1.68
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet (1998) 1.64
The chromosomal location of T-cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemia. EMBO J (1985) 1.64
Nucleotide sequence of cDNA encoding human alpha 2-macroglobulin and assignment of the chromosomal locus. Proc Natl Acad Sci U S A (1985) 1.59
The BRCA1 C-terminal domain: structure and function. Mutat Res (2000) 1.57
Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation (2001) 1.56
Molecular genetics. Colorectal cancer genes. Nature (1990) 1.56
Localization of the oncogene c-erbA1 immediately proximal to the acute promyelocytic leukaemia breakpoint on chromosome 17. Ann Hum Genet (1985) 1.55
The genomic sequence and analysis of the swine major histocompatibility complex. Genomics (2006) 1.53
The effects of feeding tetracycline, nitrovin and quindoxin on the drug-resistance of coli-aerogenes bacteria from calves and pigs. J Appl Bacteriol (1975) 1.51
Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet (1997) 1.50
Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) (2000) 1.50
The crystal structure of the catalytic domain of the site-specific recombination enzyme gamma delta resolvase at 2.7 A resolution. Cell (1990) 1.49
Breast-feeding of very low birth weight infants. J Pediatr (1993) 1.45
Human gene mapping using an X/autosome translocation. Somatic Cell Genet (1976) 1.44
The human type II collagen gene (COL2A1) assigned to 12q14.3. Ann Hum Genet (1986) 1.44
PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci (2001) 1.42
A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1). Am J Hum Genet (1993) 1.42
A trap of our own making. Anesthesiology (1995) 1.41
An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res (1992) 1.40
p97 and close encounters of every kind: a brief review. Biochem Soc Trans (2004) 1.40
Disease losses and research priorities. Vet Rec (1989) 1.39
In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci U S A (1996) 1.39
The distribution of O-antigen types of Escherichia coli in normal calves, compared with man, and their R plasmid carriage. J Appl Bacteriol (1976) 1.36
The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII. Genes Chromosomes Cancer (1992) 1.34
Simple clinical method of measuring gastric emptying of solid meals. Gut (1976) 1.33
Amino acid sequence analysis of the annexin super-gene family of proteins. Eur J Biochem (1991) 1.33
Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression. Proc Natl Acad Sci U S A (1982) 1.33
Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J Cell Sci (1997) 1.32
T4 phage beta-glucosyltransferase: substrate binding and proposed catalytic mechanism. J Mol Biol (1999) 1.32
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood (1997) 1.31
Regional localization of the human alpha 2(I) collagen gene on chromosome 7 by molecular hybridization. Cytogenet Cell Genet (1983) 1.31
Solution structure and interaction surface of the C-terminal domain from p47: a major p97-cofactor involved in SNARE disassembly. J Mol Biol (2001) 1.30